🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/05/2011 | 34,70 | 34,90 | 34,43 | 34,55 | -0,47% | 1,37% | 10.996.559 |
| 26/05/2011 | 35,01 | 35,11 | 34,45 | 34,71 | -0,84% | 1,91% | 17.826.794 |
| 25/05/2011 | 34,98 | 35,17 | 34,91 | 35,01 | -0,49% | 0,74% | 11.801.947 |
| 24/05/2011 | 35,20 | 35,34 | 35,11 | 35,18 | -0,08% | 0,68% | 12.074.742 |
| 23/05/2011 | 34,99 | 35,30 | 34,94 | 35,21 | -0,43% | 1,01% | 13.201.761 |
| 20/05/2011 | 35,67 | 35,76 | 35,20 | 35,36 | -0,86% | 1,58% | 11.870.696 |
| 19/05/2011 | 35,88 | 35,93 | 35,45 | 35,67 | -0,53% | 1,33% | 11.948.353 |
| 18/05/2011 | 35,54 | 35,90 | 35,41 | 35,86 | +0,83% | 1,37% | 13.604.822 |
| 17/05/2011 | 35,49 | 35,63 | 35,01 | 35,56 | -0,08% | 1,75% | 21.363.061 |
| 16/05/2011 | 35,36 | 35,84 | 35,31 | 35,59 | +0,59% | 1,51% | 19.638.682 |
| 13/05/2011 | 35,33 | 35,59 | 35,16 | 35,38 | -0,32% | 1,22% | 12.047.284 |
| 12/05/2011 | 35,02 | 35,56 | 34,90 | 35,50 | +1,56% | 1,88% | 16.706.692 |
| 11/05/2011 | 35,09 | 35,26 | 34,80 | 34,95 | -0,38% | 1,31% | 12.463.759 |
| 10/05/2011 | 34,88 | 35,11 | 34,83 | 35,09 | +0,79% | 0,79% | 10.061.743 |
| 09/05/2011 | 34,46 | 34,90 | 34,45 | 34,81 | +0,25% | 1,33% | 11.247.974 |
| 06/05/2011 | 34,86 | 35,07 | 34,63 | 34,72 | +0,39% | 1,26% | 13.386.733 |
| 05/05/2011 | 34,78 | 34,96 | 34,51 | 34,59 | -0,85% | 1,29% | 17.279.214 |
| 04/05/2011 | 34,69 | 35,07 | 34,61 | 34,89 | +0,41% | 1,32% | 18.234.257 |
| 03/05/2011 | 34,58 | 34,96 | 34,42 | 34,74 | +0,28% | 1,57% | 18.571.713 |
| 02/05/2011 | 34,77 | 34,90 | 34,52 | 34,65 | +1,00% | 1,10% | 19.269.890 |
| 29/04/2011 | 34,33 | 34,59 | 34,00 | 34,30 | +0,50% | 1,72% | 19.843.880 |
| 28/04/2011 | 34,01 | 34,16 | 33,84 | 34,13 | +0,39% | 0,95% | 14.096.962 |
| 27/04/2011 | 33,59 | 34,10 | 33,44 | 34,00 | +1,63% | 1,96% | 21.360.860 |
| 26/04/2011 | 32,86 | 33,55 | 32,81 | 33,45 | +2,13% | 2,24% | 22.532.000 |
| 25/04/2011 | 32,16 | 32,82 | 32,09 | 32,76 | +0,85% | 2,28% | 10.088.258 |
| 21/04/2011 | 32,70 | 32,72 | 32,40 | 32,48 | +0,00% | 0,96% | 16.567.832 |
| 20/04/2011 | 32,51 | 32,66 | 32,40 | 32,48 | +0,86% | 0,82% | 14.903.294 |
| 19/04/2011 | 32,39 | 32,55 | 31,98 | 32,20 | -0,53% | 1,74% | 15.922.474 |
| 18/04/2011 | 32,63 | 32,72 | 32,30 | 32,38 | -1,68% | 1,29% | 18.642.558 |
| 15/04/2011 | 33,30 | 33,37 | 32,87 | 32,93 | +1,92% | 1,49% | 38.676.230 |